Ann T. Hollenbeck

Ann Hollenbeck advises clients in the health care and life sciences industry on digital health, artificial intelligence, human subjects research, organ transplant, pharmacy/340B, and fraud and abuse matters. Ann also represents hospitals, academic medical centers, and technology companies, as well as ambulatory surgery centers and telemedicine providers, in such transactional matters as mergers and acquisitions, joint ventures, and physician-hospital co-ownership and co-management arrangements. She regularly advises these entities on the negotiation of clinical trial-related agreements, including virtual clinical trials, in addition to related regulatory matters, such as Medicare reimbursement and institutional review board responsibilities.

Ann's recent experience includes advising hospitals on organ transplant matters before the Organ Procurement and Transplantation Network (OPTN) and United Network for Organ Sharing (UNOS). Ann has guided clients on international telehealth and in-person care in South America, Europe, and Africa. Ann has also recently assisted clients in self-disclosure matters with the Centers for Medicare & Medicaid Services (CMS), Department of Justice (DOJ), and the Drug Enforcement Administration (DEA).

Ann previously served as assistant general counsel at the University of Michigan. She is a member of the American Health Lawyers Association and of the State Bar of Michigan (former chair, Health Law Section). Ann is a member of the board of directors of Gift of Life Michigan (organ procurement organization).

Ann has been quoted in publications, such as MedPage Today and Crain's Detroit Business, and has published on various health care topics, including digital health and pharmacy/controlled substances matters.

Ann is the Partner-in-Charge of the Detroit Office.